Protagenic Therapeutics, Inc.new

Company snapshot

Protagenic is a neuropeptide medicine company focused entirely on the biology of modulating stress responses. No direct action on serotonin. No sedation. No psychedelic-assisted experiences requiring specialized clinics and intensive monitoring. A targeted, mechanistically precise approach to the brain's own stress-control chemistry—whose action will have rapid onset and without the normal side ef

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Protagenic Therapeutics, Inc.new. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Protagenic Therapeutics, Inc.new.

1. Jun 8, 2026 Clinical update

   PT00114-001A — Phase 1

View all clinical trial activity →

• What is Protagenic Therapeutics, Inc.new?

  Protagenic Therapeutics is a pharma organization headquartered in NEW YORK, NY, USA. It trades on NYSE under ticker PTIX. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sourc

• Is Protagenic Therapeutics, Inc.new publicly traded?

  Yes. Protagenic Therapeutics, Inc.new is listed with ticker PTIX on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Protagenic Therapeutics, Inc.new develop or market?

  We link 2 drug profile(s) where Protagenic Therapeutics, Inc.new is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/protagenic-therapeutics-inc-new#company-drugs.

• What are the latest developments for Protagenic Therapeutics, Inc.new?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Protagenic Therapeutics, Inc.new focus on?

  No specific therapeutic focus areas are currently identified for Protagenic Therapeutics, Inc.new in our database.